These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 26756974)

  • 1. Nanofiltrated C1-esterase-inhibitor in the prophylactic treatment of bradykinin-mediated angioedema.
    Greve J; Hahn J; Nordmann M; Schuler PJ; Bas M; Hoffmann TK; Hajdu Z; Buchberger M; Strassen U
    Transfusion; 2016 May; 56(5):1022-9. PubMed ID: 26756974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HAE update: determining optimal patient specific therapy.
    Gower RG
    Allergy Asthma Proc; 2013; 34(1):7-12. PubMed ID: 23406928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
    Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O;
    Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Hereditary Angioedema.
    Caballero T
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):1-16. PubMed ID: 33602658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatment options for hereditary angioedema due to C1 inhibitor deficiency.
    Wu MA; Zanichelli A; Mansi M; Cicardi M
    Expert Opin Pharmacother; 2016; 17(1):27-40. PubMed ID: 26512744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic approaches in hereditary angioedema.
    Antoniu SA
    Clin Rev Allergy Immunol; 2011 Aug; 41(1):114-22. PubMed ID: 21279474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of drugs-associated non-hereditary angioedema mediated by bradykinin].
    Muller Y; Harr T
    Rev Med Suisse; 2016 Jan; 12(500):11-2. PubMed ID: 26946694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis in hereditary angioedema (HAE) with C1 inhibitor deficiency.
    Greve J; Strassen U; Gorczyza M; Dominas N; Frahm UM; Mühlberg H; Wiednig M; Zampeli V; Magerl M
    J Dtsch Dermatol Ges; 2016 Mar; 14(3):266-75. PubMed ID: 26972189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evidence based therapeutic approach to hereditary and acquired angioedema.
    Bork K
    Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):354-62. PubMed ID: 24983294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icatibant as acute treatment for hereditary angioedema in adults.
    Farkas H
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):779-88. PubMed ID: 27123689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary angioedema: an update on causes, manifestations and treatment.
    Longhurst HJ; Bork K
    Br J Hosp Med (Lond); 2019 Jul; 80(7):391-398. PubMed ID: 31283393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
    Sabharwal G; Craig T
    Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema.
    Henry Li H; Riedl M; Kashkin J
    Clin Rev Allergy Immunol; 2019 Apr; 56(2):207-218. PubMed ID: 29909591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks.
    Hide M; Horiuchi T; Ohsawa I; Andresen I; Fukunaga A
    Allergol Int; 2021 Jan; 70(1):45-54. PubMed ID: 32919903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.
    Jacobs J; Neeno T
    Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and therapeutic management of hereditary angioedema due to C1-inhibitor deficiency: the Italian experience.
    Cancian M;
    Curr Opin Allergy Clin Immunol; 2015 Aug; 15(4):383-91. PubMed ID: 26106828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deucrictibant for angioedema due to acquired C1-inhibitor deficiency: A randomized-controlled trial.
    Petersen RS; Fijen LM; Kelder JP; Cohn DM
    J Allergy Clin Immunol; 2024 Jul; 154(1):179-183. PubMed ID: 38494092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Long-Term Prophylactic Treatment With Subcutaneous C1 Esterase Inhibitor in a Patient With Hereditary Angioedema.
    Hahn J; Nordmann-Kleiner M; Trainotti S; Hoffmann TK; Greve J
    J Pharm Pract; 2020 Dec; 33(6):907-911. PubMed ID: 31234699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hereditary angioedema due to C1-esterase inhibitor deficiency : novel approaches].
    Stehlin F; Ribi C
    Rev Med Suisse; 2020 Apr; 16(689):675-678. PubMed ID: 32270933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the cost and quality-of-life impact of on-demand-only medications for adults with hereditary angioedema.
    Castaldo AJ; Jervelund C; Corcoran D; Boysen HB; Christiansen SC; Zuraw BL
    Allergy Asthma Proc; 2021 Mar; 42(2):108-117. PubMed ID: 33581742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.